{"doi":"10.53879/id.50.06.p0005","title":"DRUG PROFILE OF ANASTROZOLE: AN AROMATASE INHIBITOR","abstract":"<jats:p>Anastrozole is a selective non-steroidal aromatase inhibitor and is the first drug approved by FDA in adjuvant hormonal therapy. Anastrozole was proved superior to tamoxifen for the treatment of hormoneresponsive breast cancer. In this review, we have highlighted the profile of this drug including its pharmacodynamics, pharmacokinetics, drug interactions, clinical studies and side effects.</jats:p>","journal":"INDIAN DRUGS","year":2013,"id":638421,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1658159,"name":"P. Kaur","orcid":null,"position":1,"is_corresponding":false},{"id":1658162,"name":"J Kumari","orcid":null,"position":2,"is_corresponding":false},{"id":196576,"name":"M Kumari","orcid":null,"position":3,"is_corresponding":false},{"id":53616,"name":"A Rani","orcid":null,"position":4,"is_corresponding":false},{"id":1583480,"name":"A. Bansal","orcid":null,"position":5,"is_corresponding":false},{"id":1658167,"name":"M Kaur","orcid":null,"position":6,"is_corresponding":false},{"id":1658170,"name":"R. K. Gill","orcid":null,"position":7,"is_corresponding":false},{"id":1658174,"name":"J Bariwal","orcid":null,"position":8,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"DRUG PROFILE OF ANASTROZOLE: AN AROMATASE INHIBITOR","abstract":"<jats:p>Anastrozole is a selective non-steroidal aromatase inhibitor and is the first drug approved by FDA in adjuvant hormonal therapy. Anastrozole was proved superior to tamoxifen for the treatment of hormoneresponsive breast cancer. In this review, we have highlighted the profile of this drug including its pharmacodynamics, pharmacokinetics, drug interactions, clinical studies and side effects.</jats:p>","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19910364","pmcid":null,"openalex_id":"https://openalex.org/W3201712016","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.32672258,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://www.indiandrugsonline.org//download/June_2013_50_6_5.pdf","host_type":"publisher"},{"url":"https://doi.org/10.53879/id.50.06.p0005","host_type":"journal"}],"fields_of_study":["Estrogen and related hormone effects","Computational Drug Discovery Methods","Bioactive Compounds and Antitumor Agents"],"mesh_terms":[],"keywords":["Anastrozole","Aromatase inhibitor","Tamoxifen","Aromatase","Drug","Pharmacology","Pharmacodynamics","Pharmacokinetics","Medicine","Adjuvant","Breast cancer","Oncology","Internal medicine","Cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T20:38:35.461868Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}